Peripheral artery disease: current insight into the disease and its diagnosis and management
- PMID: 20592174
- PMCID: PMC2894725
- DOI: 10.4065/mcp.2010.0133
Peripheral artery disease: current insight into the disease and its diagnosis and management
Abstract
Peripheral artery disease (PAD), which comprises atherosclerosis of the abdominal aorta, iliac, and lower-extremity arteries, is underdiagnosed, undertreated, and poorly understood by the medical community. Patients with PAD may experience a multitude of problems, such as claudication, ischemic rest pain, ischemic ulcerations, repeated hospitalizations, revascularizations, and limb loss. This may lead to a poor quality of life and a high rate of depression. From the standpoint of the limb, the prognosis of patients with PAD is favorable in that the claudication remains stable in 70% to 80% of patients over a 10-year period. However, the rate of myocardial infarction, stroke, and cardiovascular death in patients with both symptomatic and asymptomatic PAD is markedly increased. The ankle brachial index is an excellent screening test for the presence of PAD. Imaging studies (duplex ultrasonography, computed tomographic angiography, magnetic resonance angiography, catheter-based angiography) may provide additional anatomic information if revascularization is planned. The goals of therapy are to improve symptoms and thus quality of life and to decrease the cardiovascular event rate (myocardial infarction, stroke, cardiovascular death). The former is accomplished by establishing a supervised exercise program and administering cilostazol or performing a revascularization procedure if medical therapy is ineffective. A comprehensive program of cardiovascular risk modification (discontinuation of tobacco use and control of lipids, blood pressure, and diabetes) will help to prevent the latter.
Figures


Comment in
-
Does vitamin D have a role in reducing the risk of peripheral artery disease?Mayo Clin Proc. 2010 Nov;85(11):1058-9; author reply 1059-60. doi: 10.4065/mcp.2010.0508. Mayo Clin Proc. 2010. PMID: 21037050 Free PMC article. No abstract available.
Similar articles
-
Medical management of peripheral arterial disease.Cardiol Rev. 2001 Jul-Aug;9(4):238-45. doi: 10.1097/00045415-200107000-00010. Cardiol Rev. 2001. PMID: 11405904 Review.
-
Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.J Clin Pharmacol. 2002 Dec;42(12):1291-8. doi: 10.1177/0091270002042012002. J Clin Pharmacol. 2002. PMID: 12463722 Review.
-
Management of peripheral arterial disease and intermittent claudication.J Am Board Fam Pract. 2001 Nov-Dec;14(6):443-50. J Am Board Fam Pract. 2001. PMID: 11757887 Review.
-
Comparative effects of cilostazol and other therapies for intermittent claudication.Am J Cardiol. 2001 Jun 28;87(12A):19D-27D. doi: 10.1016/s0002-9149(01)01673-3. Am J Cardiol. 2001. PMID: 11434896 Review.
-
Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).Int Angiol. 2010 Apr;29(2 Suppl):2-13. Int Angiol. 2010. PMID: 20357743
Cited by
-
Contrast-Enhanced Magnetic Resonance Imaging Based T1 Mapping and Extracellular Volume Fractions Are Associated with Peripheral Artery Disease.J Cardiovasc Dev Dis. 2024 Jun 14;11(6):181. doi: 10.3390/jcdd11060181. J Cardiovasc Dev Dis. 2024. PMID: 38921681 Free PMC article.
-
Peripheral arterial disease: Effects of ethanolic extracts of seed kernels of mango (Mangifera indica .L) on acute hind limb ischemia-reperfusion injury in diabetic rats.J Tradit Complement Med. 2021 May 30;11(6):520-531. doi: 10.1016/j.jtcme.2021.05.004. eCollection 2021 Nov. J Tradit Complement Med. 2021. PMID: 34765516 Free PMC article.
-
Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease.Biosci Rep. 2017 Apr 20;37(2):BSR20160502. doi: 10.1042/BSR20160502. Print 2017 Apr 30. Biosci Rep. 2017. PMID: 28250135 Free PMC article.
-
Association of lower urinary tract syndrome with peripheral arterial occlusive disease.PLoS One. 2017 Mar 16;12(3):e0170288. doi: 10.1371/journal.pone.0170288. eCollection 2017. PLoS One. 2017. PMID: 28301517 Free PMC article.
-
Improvement of peripheral artery disease with Sildenafil and Bosentan combined therapy in a patient with limited cutaneous systemic sclerosis: A case report.Medicine (Baltimore). 2017 Jun;96(25):e6988. doi: 10.1097/MD.0000000000006988. Medicine (Baltimore). 2017. PMID: 28640077 Free PMC article.
References
-
- Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317-1324 - PubMed
-
- Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113(11):e463-e654 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical